InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
60%
T+90 mean return
-3.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by F. Weber. Insider active across 1 company, notably Vivoryon Therapeutics N.V.. Aggregated, 10 reports have been published. Activity tracked since 15 September 2023. The latest transaction was filed on 17 April 2026 (Purchase). Regulator: AFM. All data is free.
Declarations10 total
150,000 shares0OptieAFM:192721
Ideal exit: 12 Jan 2027 (T+270)
30,600 shares@ €1.8110.5% of flowGewoon aandeelAFM:184722
Ideal exit: 6 Sept 2026 (T+270)
135,000 shares@ €1.503738.5% of flowGewoon aandeelAFM:181999
Ideal exit: 13 Jul 2026 (T+270)
-30,600 shares0Gewoon aandeelAFM:173753
400,000 shares0OptieAFM:171838
Ideal exit: 10 Dec 2025 (T+270)
140,000 shares0OptieAFM:159531
Ideal exit: 3 Mar 2025 (T+270)
120,000 shares0OptieAFM:152999
Ideal exit: 6 Oct 2024 (T+270)
20,000 shares@ €7.90230.0% of flowGewoon aandeelAFM:150118
Ideal exit: 30 Jul 2024 (T+270)
13,950 shares@ €7.963721.1% of flowGewoon aandeelAFM:150028
Ideal exit: 29 Jul 2024 (T+270)
421,450 shares0OptieAFM:147967
Ideal exit: 11 Jun 2024 (T+270)
10 of 10 declarations
About F. Weber
F. Weber is a director at Vivoryon Therapeutics N.V.
